Paired inhibitory and triggering NK cell receptors for HLA class I molecules

Human Immunology

Volumn 61, Issue 1, 2000, Pages 7-17

  López Botet, Miguel ^a   Bellón, Teresa ^a   Llano, Manuel ^a   Navarro, Francisco ^a   Garcı�?a, Pilar ^a   Miguel, Marı�?a de ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

CD94; HLA; KIR; Natural killer cell; Receptor

Indexed keywords

HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN RECOGNITION; ARTICLE; DOWN REGULATION; IMMUNOREGULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES; LIGANDS; RECEPTORS, IMMUNOLOGIC;

EID: 0343340004     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00161-5     Document Type: Article

References (108)

1. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., Moretta L. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol. 14:1996;619.
2. Parham P. NK cells, MHC class I antigens, and missing self. Immunol Rev. 155:1997;1.
3. Lanier L.L. NK cell receptors. Annu Rev Immunol. 16:1998;359.
4. Yokoyama W.M. Natural killer cell receptors. Curr Opin Immunol. 10:1998;298.
5. López-Botet M., Bellón T. Natural killer cell activation and inhibition by receptors for MHC class I. Curr Opin Immunol. 11:1999;301.
6. Long E.O. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol. 17:1999;875.
7. Oosterwegel M.A., Greenwald R.J., Mandelbrot D.A., Lorsbach R.B., Sharpe A.H. CTLA-4 and T cell activation. Curr Opin Immunol. 11:1999;294.
8. Raulet D.H. Development and tolerance of natural killer cells. Curr Opin Immunol. 11:1999;129.
9. Mingari M.C., Moretta A., Moretta L. Regulation of KIR expression in human T cells a safety mechanism that may impair protective T-cell responses. Immunol Today. 19:1998;153.
10. Colonna M., Navarro F., López-Botet M. A novel family of inhibitory receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. Curr Top Microbiol Immunol. 244:1999;115.
11. Wagtmann N., Rojo S., Eichler E., Mohrenweiser H., Long E.O. A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors. Curr Biol. 7:1997;615.
12. Wilson M.J., Torkar M., Trowsdale J. Genomic organization of a human killer cell inhibitory receptor gene. Tiss Antigens. 49:1997;574.
13. Selvakumar A., Steffens U., Palanisamy N., Chaganti R.S., Dupont B. Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103. Tiss Antigens. 49:1997;564.
14. Uhrberg M., Valiante N.M., Shum B.P., Shilling H.G., Lienert-Weidenbach K., Corliss B., Tyan D., Lanier L.L., Parham P. Human diversity in killer cell inhibitory receptor genes. Immunity. 7:1997;753.
15. Leibson P.J. Signal transduction during natural killer cell activation inside the mind of a killer. Immunity. 6:1997;655.
16. Vivier E., Daeron M. Immunoreceptor tyrosine-based inhibition motifs. Immunol Today. 18:1997;286.
17. Burshtyn D.N., Lam A.S., Weston M., Gupta N., Warmerdam P.A., Long E.O. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors. J Immunol. 162:1999;897.
18. Lanier L.L., Corliss B.C., Wu J., Leong C., Phillips J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 391:1998;703.
19. Olcese L., Cambiaggi A., Semenzato G., Bottino C., Moretta A., Vivier E. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol. 158:1997;5083.
20. Campbell K.S., Cella M., Carretero M., López-Botet M., Colonna M. Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex. Eur J Immunol. 28:1998;599.
21. Winter C.C., Gumperz J.E., Parham P., Long E.O., Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol. 161:1998;571.
22. Mandelboim O., Reyburn H.T., Sheu E.G., Vales-Gomez M., Davis D.M., Pazmany L., Strominger J.L. The binding site of NK receptors on HLA-C molecules. Immunity. 6:1997;341.
23. Gumperz J.E., Barber L.D., Valiante N.M., Percival L., Phillips J.H., Lanier L.L., Parham P. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J Immunol. 158:1997;5237.
24. Fan Q.R., Mosyak L., Winter C.C., Wagtmann N., Long E.O., Wiley D.C. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors. Nature. 389:1997;96. [published erratum appears in Nature 390:315, 1997].
25. Maenaka K., Juji T., Stuart D.I., Jones E.Y. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I. Structure. 7:1999;391.
26. Snyder G.A., Brooks A.G., Sun P.D. Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2. Proc Natl Acad Sci USA. 96:1999;3864.
27. Winter C.C., Long E.O. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J Immunol. 158:1997;4026.
28. Fan Q.R., Wiley D.C. Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor. J Exp Med. 190:1999;113.
29. Biassoni R., Pessino A., Malaspina A., Cantoni C., Bottino C., Sivori S., Moretta L., Moretta A. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol. 27:1997;3095.
30. Valés-Gómez M., Reyburn H.T., Erskine R.A., Strominger J. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc Natl Acad Sci USA. 95:1998;14326. [published erratum appears in Immunity 9:892].
31. López-Botet M., Navarro F., Llano M. How do NK cells sense the expression of HLA-G class Ib molecules? Semin Cancer Biol. 9:1999;19.
32. Cantoni C., Verdiani S., Falco M., Pessino A., Cilli M., Conte R., Pende D., Mikaelsson M.S., Moretta L., Biassoni R. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol. 28:1998;1980.
33. Rajagopalan S., Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med. 189:1999;1093.
34. Ponte M., Cantoni C., Biassoni R., Tradori-Cappai A., Bentivoglio G., Vitale C., Bertone S., Moretta A., Moretta L., Mingari M.C. Inhibitory receptors sensing HLA-G1 molecules in pregnancy decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA. 96:1999;5674.
35. Zimmer J., Donato L., Hanau D., Cazenave J.P., Tongio M.M., Moretta A., de la Salle H. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J Exp Med. 187:1998;117.
36. Dorfman J.R., Zerrahn J., Coles M.C., Raulet D.H. The basis for self-tolerance of natural killer cells in beta2- microglobulin- and TAP-1- mice. J Immunol. 159:1997;5219.
37. Höglund P., Glas R., Menard C., Kase A., Johansson M.H., Franksson L., Lemmonier F., Kärre K. Beta2-microglobulin-deficient NK cells show increased sensitivity to MHC class I-mediated inhibition, but self tolerance does not depend upon target cell expression of H-2Kb and Db heavy chains. Eur J Immunol. 28:1998;370.
38. Salcedo M., Andersson M., Lemieux S., Van K.L., Chambers B.J., Ljunggren H.G. Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice. Eur J Immunol. 28:1998;1315.
39. Wang L.L., Mehta I.K., LeBlanc P.A., Yokoyama W.M. Mouse natural killer cells express gp49B1, a structural homologue of human killer inhibitory receptors. J Immunol. 158:1997;13.
40. Kubagawa H., Burrows P.D., Cooper M.D. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci USA. 94:1997;5261.
41. Nakamura M.C., Niemi E.C., Fisher M.J., Shultz L.D., Seaman W.E., Ryan J.C. Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J Exp Med. 185:1997;673.
42. McVicar D.W., Taylor L.S., Gosselin P., Willette-Brown J., Mikhael A.I., Geahlen R.L., Nakamura M.C., Linnemeyer P., Seaman W.E., Anderson S.K., Ortaldo J.R., Mason L.H. DAP12-mediated signal transduction in natural killer cells A dominant role for the syk protein-tyrosine kinase. J Biol Chem. 273:1998;32934.
43. Smith K.M., Wu J., Bakker A.B., Phillips J.H., Lanier L.L. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J Immunol. 161:1998;7.
44. Westgaard I.H., Berg S.F., Orstavik S., Fossum S., Dissen E. Identification of a human member of the Ly-49 multigene family. Eur J Immunol. 28:1998;1839.
45. Brown M.H., Boles K., van der Merwe A., Kumar V., Mathew P.A., Neil B.A. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med. 188:1998;2083.
46. Schatzle J.D., Sheu S., Stepp S.E., Mathew P.A., Bennett M., Kumar V. Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4. Proc Natl Acad Sci USA. 96:1999;3870.
47. Nakajima H., Cella M., Langen H., Friedlein A., Colonna M. Activating interactions in human NK cell recognition the role of 2B4-CD48. Eur J Immunol. 29:1999;1676.
48. Tangye S.G., Lazetic S., Woollatt E., Sutherland G.R., Lanier L.L., Phillips J.H. Cutting edge human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol. 162:1999;6981.
49. Agrawal S., Marquet J., Freeman G.J., Tawab A., Bouteiller P.L., Roth P., Bolton W., Ogg G., Boumsell L., Bensussan A. Cutting edge MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J Immunol. 162:1999;1223.
50. Mandelboim O., Malik P., Davis D.M., Jo C.H., Boyson J.E., Strominger J.L. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc Natl Acad Sci USA. 96:1999;5640.
51. Meyaard L., Adema G.J., Chang C., Woollatt E., Sutherland G.R., Lanier L.L., Phillips J.H. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity. 7:1997;283.
52. Pessino A., Sivori S., Bottino C., Malaspina A., Morelli L., Moretta L., Biassoni R., Moretta A. Molecular cloning of NKp46 a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med. 188:1998;953.
53. Sivori S., Pende D., Bottino C., Marcenaro E., Pessino A., Biassoni R., Moretta L., Moretta A. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol. 29:1999;1656.
54. Cantoni C., Bottino C., Vitale M., Pessino A., Augugliaro R., Malaspina A., Parolini S., Moretta L., Moretta A., Biassoni R. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med. 189:1999;787.
55. Vitale M., Bottino C., Sivori S., Sanseverino L., Castriconi R., Marcenaro E., Augugliaro R., Moretta L., Moretta A. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med. 187:1998;2065.
56. Samaridis J., Colonna M. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol. 27:1997;660.
57. Colonna M., Navarro F., Bellón T., Llano M., Garcia P., Samaridis J., Angman L., Cella M., López-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 186:1997;1809.
58. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., Hsu M.L. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity. 7:1997;273.
59. Borges L., Hsu M.L., Fanger N., Kubin M., Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol. 159:1997;5192.
60. Torkar M., Norgate Z., Colonna M., Trowsdale J., Wilson M.J. isotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complex. Eur J Immunol. 28:1998;3959.
61. Nakajima H., Samaridis J., Angman L., Colonna M. Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain. J Immunol. 162:1999;5.
62. Colonna M., Samaridis J., Cella M., Angman L., Allen R.L., O'Callaghan C.A., Dunbar R., Ogg G.S., Cerundolo V., Rolink A. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol. 160:1998;3096.
63. Navarro F., Llano M., Bellón T., Colonna M., Geraghty D.E., López-Botet M. The ILT2 (LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol. 29:1999;277.
64. Banham A.H., Colonna M., Cella M., Micklem K.J., Pulford K., Willis A.C., Mason D.Y. Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily. J Leukoc Biol. 65:1999;841.
65. Allan D.S., Colonna M., Lanier L.L., Churakova T.D., Abrams J.S., Ellis S.A., McMichael A.J., Braud V.M. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med. 189:1999;1149.
66. Leong C.C., Chapman T.L., Bjorkman P.J., Formankova D., Mocarski E.S., Phillips J.H., Lanier L.L. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med. 187:1998;1681. [published erratum appears in J Exp Med 188:614, 1998].
67. Farrell H.E., Degli-Esposti M.A., Davis-Poynter N.J. Cytomegalovirus evasion of natural killer cell responses. Immunol Rev. 168:1999;187.
68. Cosman D, Fanger N, Borges L: Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers. Immunol Rev 168:177:177, 1999.
69. Fanger N.A., Cosman D., Peterson L., Braddy S.C., Maliszewski C.R., Borges L. The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor- mediated signaling in monocytes. Eur J Immunol. 28:1998;3423.
70. López-Botet M., Carretero M., Bellón T., Pérez-Villar J.J., Llano M., Navarro F. The CD94/NKG2 C-type lectin receptor complex. Curr Top Microbiol Immunol. 230:1998;41.
71. Rodríguez A., Carretero M., Glienke J., Bellón T., Ramírez A., Lehrach H., Francis F., López-Botet M. Structure of the human CD94 C-type lectin gene. Immunogenetics. 47:1998;305.
72. Boyington J.C., Riaz A.N., Patamawenu A., Coligan J.E., Brooks A.G., Sun P.D. Structure of CD94 reveals a novel C-type lectin fold implications for the NK cell-associated CD94/NKG2 receptors. Immunity. 10:1999;75.
73. Carretero M., Palmieri G., Llano M., Tullio V., Santoni A., Geraghty D.E., López-Botet M. Specific engagement of the CD94/NKG2A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2A evidence for receptor function in heterologous transfectants. Eur J Immunol. 28:1998;1280.
74. Le Drean E., Vely F., Olcese L., Cambiaggi A., Guia S., Krystal G., Gervois N., Moretta A., Jotereau F., Vivier E. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur J Immunol. 28:1998;264.
75. Palmieri G., Tullio V., Zingoni A., Piccoli M., Frati L., López-Botet M., Santoni A. CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells. J Immunol. 162:1999;7181.
76. Cantoni C., Biassoni R., Pende D., Sivori S., Accame L., Pareti L., Semenzato G., Moretta L., Moretta A., Bottino C. The activating form of CD94 receptor complex CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Eur J Immunol. 28:1998;327.
77. Lanier L.L., Corliss B., Wu J., Phillips J.H. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity. 8:1998;693.
78. Carretero M., Cantoni C., Bellón T., Bottino C., Biassoni R., Rodríguez A., Pérez-Villar J., Moretta L., Moretta A., López-Botet M. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol. 27:1997;563.
79. Mingari M.C., Ponte M., Bertone S., Schiavetti F., Vitale C., Bellomo R., Moretta A., Moretta L. HLA class I-specific inhibitory receptors in human T lymphocytes interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Proc Natl Acad Sci USA. 95:1998;1172.
80. Bertone S., Schiavetti F., Bellomo R., Vitale C., Ponte M., Moretta L., Mingari M.C. Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur J Immunol. 29:1999;23.
81. Andre P., Brunet C., Guia S., Gallais H., Sampol J., Vivier E., Dignat-George F. Differential regulation of killer cell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals. Eur J Immunol. 29:1999;1076.
82. Bakker A.B., Phillips J.H., Figdor C.G., Lanier L.L. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL. J Immunol. 160:1998;5239.
83. Ikeda H., Lethe B., Lehmann F., van Baren B.N., Baurain J.F., de Smet S.C., Chambost H., Vitale M., Moretta A., Boon T., Coulie P.G. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity. 6:1997;199.
84. Pende D., Accame L., Pareti L., Mazzocchi A., Moretta A., Parmiani G., Moretta L. The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles. Eur J Immunol. 28:1998;2384.
85. Speiser D.E., Valmori D., Rimoldi D., Pittet M.J., Lienard D., Cerundolo V., MacDonald H.R., Cerottini J.C., Romero P. CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients. Eur J Immunol. 29:1999;1990.
86. Braud V.M., Allan D.S., O'Callaghan C.A., Söderström K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMichael A.J. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:1998;795.
87. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med. 187:1998;813.
88. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., López-Botet M., Geraghty D. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA. 95:1998;5199.
89. Lee N., Goodlett D.R., Ishitani A., Marquardt H., Geraghty D.E. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol. 160:1998;4951.
90. Braud V., Jones E.Y., McMichael A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol. 27:1997;1164.
91. Braud V.M., Allan D.S., Wilson D., McMichael A.J. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr Biol. 8:1998;1.
92. O'Callaghan C.A., Tormo J., Willcox B.E., Braud V.M., Jakobsen B.K., Stuart D.I., McMichael A.J., Bell J.I., Jones E.Y. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Molec Cell. 1:1998;531.
93. Furukawa H., Yabe T., Akaza T., Tadokoro K., Tohma S., Inoue T., Tokunaga K., Yamamoto K., Geraghty D.E., Juji T. Cell surface expression of HLA-E molecules on PBMC from a TAP1-deficient patient. Tiss Antigens. 53:1999;292.
94. Llano M., Lee N., Navarro F., Garcia P., Albar J.P., Geraghty D.E., Lopez-Botet M. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors preferential response to an HLA-G-derived nonamer. Eur J Immunol. 28:1998;2854.
95. Brooks A.G., Borrego F., Posch P.E., Patamawenu A., Scorzelli C.J., Ulbrecht M., Weiss E.H., Coligan J.E. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J Immunol. 162:1999;305.
96. Valés-Gómez M., Reyburn H.T., Erskine R.A., López-Botet M., Strominger J.L. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 18:1999;4250.
97. Cohen G.B., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity. 10:1999;661.
98. Berg S.F., Dissen E., Westgaard I.H., Fossum S. Two genes in the rat homologous to human NKG2. Eur J Immunol. 28:1998;444.
99. Ho E.L., Heusel J.W., Brown M.G., Matsumoto K., Scalzo A.A., Yokoyama W.M. Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells. Proc Natl Acad Sci USA. 95:1998;6320.
100. Vance R.E., Tanamachi D.M., Hanke T., Raulet D.H. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur J Immunol. 27:1997;3236.
101. Dissen E., Berg S.F., Westgaard I.H., Fossum S. Molecular characterization of a gene in the rat homologous to human CD94. Eur J Immunol. 27:1997;2080.
102. Vance R.E., Kraft J.R., Altman J.D., Jensen P.E., Raulet D.H. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med. 188:1998;1841.
103. Salcedo M., Bousso P., Ljunggren H.G., Kourilsky P., Abastado J.P. The Qa-1b molecule binds to a large subpopulation of murine NK cells. Eur J Immunol. 28:1998;4356.
104. Bai A., Broen J., Forman J. The pathway for processing leader-derived peptides that regulate the maturation and expression of Qa-1b. Immunity. 9:1998;413.
105. Aldrich C.J., DeCloux A., Woods A.S., Cotter R.J., Soloski M.J., Forman J. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell. 79:1994;649.
106. Bellón T., Heredia A.B., Llano M., Minguela A., Rodriguez A., López-Botet M., Aparicio P. Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer. J Immunol. 162:1999;3996.
107. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:1999;727.
108. Wu J., Song Y., Bakker A.B., Bauer S., Spies T., Lanier L.L., Phillips J.H. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 285:1999;730.